A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
Clinical trial NCT05389319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05389319
- Sponsor
- University Hospital Tuebingen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-24
- Primary completion
- 2026-12-31
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.